These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3615992)

  • 1. Biologically motivated cancer risk models.
    Thorslund TW; Brown CC; Charnley G
    Risk Anal; 1987 Mar; 7(1):109-19. PubMed ID: 3615992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concepts in multistage carcinogenesis.
    Ito N; Hasegawa R; Imaida K; Hirose M; Asamoto M; Shirai T
    Crit Rev Oncol Hematol; 1995 Nov; 21(1-3):105-133. PubMed ID: 8822499
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of the stage of progression in hepatocarcinogenesis in the rat.
    Pitot HC
    Basic Life Sci; 1991; 57():3-18. PubMed ID: 1814289
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic analysis of multistage hepatocarcinogenesis.
    Poole TM; Chiaverotti TA; Carabeo RA; Drinkwater NR
    Prog Clin Biol Res; 1996; 395():33-45. PubMed ID: 8895982
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell biology of hepatocarcinogenesis.
    Saeter G; Seglen PO
    Crit Rev Oncog; 1990; 1(4):437-66. PubMed ID: 1964598
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimal neoplasias in experimental liver carcinogenesis.
    Rabes HM
    Recent Results Cancer Res; 1988; 106():21-7. PubMed ID: 3285413
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemical carcinogenesis: the liver as a model.
    Farber E; Sarma DS
    Pathol Immunopathol Res; 1986; 5(1):1-28. PubMed ID: 3022277
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene amplification during stages of carcinogenesis.
    Locker J
    Basic Life Sci; 1991; 57():157-66; discussion 166-70. PubMed ID: 1814281
    [No Abstract]   [Full Text] [Related]  

  • 9. Quantitative aspects of drug-mediated tumour promotion in liver and its toxicological implications.
    Kunz W; Schaude G; Schwarz M; Tennekes H
    Carcinog Compr Surv; 1982; 7():111-25. PubMed ID: 7039825
    [No Abstract]   [Full Text] [Related]  

  • 10. The peroxisome proliferator class of non-genotoxic hepatocarcinogens synergize with epidermal growth factor to promote clonal expansion of initiated rat hepatocytes.
    James NH; Roberts RA
    Carcinogenesis; 1994 Dec; 15(12):2687-94. PubMed ID: 8001222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine.
    Ströbel P; Klimek F; Zerban H; Kopp-Schneider A; Bannasch P
    Carcinogenesis; 1998 Dec; 19(12):2069-80. PubMed ID: 9886559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clonal growth model: time-course simulations of liver foci growth following penta- or hexachlorobenzene treatment in a medium-term bioassay.
    Ou YC; Conolly RB; Thomas RS; Xu Y; Andersen ME; Chubb LS; Pitot HC; Yang RS
    Cancer Res; 2001 Mar; 61(5):1879-89. PubMed ID: 11280742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of hepatocarcinogenesis in rainbow trout with carbon tetrachloride.
    Kotsanis N; Metcalfe CD
    Bull Environ Contam Toxicol; 1991 Jun; 46(6):879-86. PubMed ID: 1863795
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic susceptibility to tumor progression in mouse skin carcinogenesis.
    Stern MC; Conti CJ
    Prog Clin Biol Res; 1996; 395():47-55. PubMed ID: 8895983
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered hepatic foci: their role in murine hepatocarcinogenesis.
    Pitot HC
    Annu Rev Pharmacol Toxicol; 1990; 30():465-500. PubMed ID: 2188576
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor promotion in the liver.
    Schulte-Hermann R
    Arch Toxicol; 1985 Aug; 57(3):147-58. PubMed ID: 3904674
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative analysis of enzyme-altered foci in rat hepatocarcinogenesis experiments--I. Single agent regimen.
    Moolgavkar SH; Luebeck EG; de Gunst M; Port RE; Schwarz M
    Carcinogenesis; 1990 Aug; 11(8):1271-8. PubMed ID: 2143703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preneoplastic lesions as end points in carcinogenicity testing. I. Hepatic preneoplasia.
    Bannasch P
    Carcinogenesis; 1986 May; 7(5):689-95. PubMed ID: 2870822
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of hyperplasia in liver carcinogenesis.
    Mirsalis JC; Steinmetz KL
    Prog Clin Biol Res; 1990; 331():149-61. PubMed ID: 2179957
    [No Abstract]   [Full Text] [Related]  

  • 20. Chrysin abrogates early hepatocarcinogenesis and induces apoptosis in N-nitrosodiethylamine-induced preneoplastic nodules in rats.
    Khan MS; Devaraj H; Devaraj N
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):85-94. PubMed ID: 21167192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.